110 related articles for article (PubMed ID: 24957138)
1. Do glial cells play an anti-oxidative role in Huntington's disease?
Gao Y; Chu SF; Li JP; Zuo W; Wen ZL; He WB; Yan JQ; Chen NH
Free Radic Res; 2014 Oct; 48(10):1135-44. PubMed ID: 24957138
[TBL] [Abstract][Full Text] [Related]
2. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
Trushina E; McMurray CT
Neuroscience; 2007 Apr; 145(4):1233-48. PubMed ID: 17303344
[TBL] [Abstract][Full Text] [Related]
5. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
Besson MT; Dupont P; Fridell YW; Liévens JC
Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711
[TBL] [Abstract][Full Text] [Related]
6. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
8. Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.
Stack EC; Matson WR; Ferrante RJ
Ann N Y Acad Sci; 2008 Dec; 1147():79-92. PubMed ID: 19076433
[TBL] [Abstract][Full Text] [Related]
9. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
[TBL] [Abstract][Full Text] [Related]
10. [The molecular bases of Huntington's disease: the role played by oxidative stress].
Tasset I; Sánchez F; Túnez I
Rev Neurol; 2009 Oct 16-31; 49(8):424-9. PubMed ID: 19816846
[TBL] [Abstract][Full Text] [Related]
11. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
12. Free radical damage and oxidative stress in Huntington's disease.
Borlongan CV; Kanning K; Poulos SG; Freeman TB; Cahill DW; Sanberg PR
J Fla Med Assoc; 1996 May; 83(5):335-41. PubMed ID: 8666972
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and oxidative stress in neurodegenerative diseases.
Radi E; Formichi P; Battisti C; Federico A
J Alzheimers Dis; 2014; 42 Suppl 3():S125-52. PubMed ID: 25056458
[TBL] [Abstract][Full Text] [Related]
14. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
15. The role of iron imaging in Huntington's disease.
van den Bogaard SJ; Dumas EM; Roos RA
Int Rev Neurobiol; 2013; 110():241-50. PubMed ID: 24209441
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.
Chen CM
Chang Gung Med J; 2011; 34(2):135-52. PubMed ID: 21539755
[TBL] [Abstract][Full Text] [Related]
17. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.
Kumar A; Ratan RR
J Huntingtons Dis; 2016 Oct; 5(3):217-237. PubMed ID: 27662334
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in neurodegenerative diseases.
Chen X; Guo C; Kong J
Neural Regen Res; 2012 Feb; 7(5):376-85. PubMed ID: 25774178
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle re-entry of neurons and reactive neuroblastosis in Huntington's disease: Possibilities for neural-glial transition in the brain.
Manickam N; Radhakrishnan RK; Vergil Andrews JF; Selvaraj DB; Kandasamy M
Life Sci; 2020 Dec; 263():118569. PubMed ID: 33049278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
